Insurance Coverage Policies for Personalized Medicine

Andrew M. Hresko, Susanne B. Haga

Journal of Personalized Medicine

Health Insurance DesignPgx TestsPharmacogenomicsInsurance RegulationsPublic Health +16

Health Technology Assessment and Private Payers' Coverage of Personalized Medicine

Julia R. Trosman, Stephanie L. Van Bebber, Kathryn A. Phillips

Journal of Oncology Practice

Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene Assay

Julia R. Trosman, Stephanie L. Van Bebber, Kathryn A. Phillips

Journal of Oncology Practice

Closing the Evidence Gap in the Use of Emerging Testing Technologies in Clinical Practice

Kathryn A. Phillips

JAMA

Point-of-care TestingOtorhinolaryngologySurgeryEvidence GapMedical Diagnosis +17

Challenges of Coverage Policy Development for Next-Generation Tumor Sequencing Panels: Experts and Payers Weigh In

Julia R. Trosman, Christine B. Weldon, Robin Kate Kelley, +1

Journal of the National Comprehensive Cancer Network

Overcoming the Reimbursement Barriers for Clinical Sequencing

Patricia A. Deverka, David Kaufman, Amy L. McGuire

JAMA

Website Uses CookiesMedicineNext-generation SequencingPatient SafetyClinical Trials +13

Payer decision making for next-generation sequencing–based genetic tests: insights from cell-free DNA prenatal screening

Andrew Dervan, Patricia A. Deverka, Julia R. Trosman, +3

Genetics in Medicine

Reproductive Genetic CounselingGenetic TestingPayer DecisionGenetic TestsPrenatal Genetic Testing +10

Availability and payer coverage of BRCA1/2 tests and gene panels

Elizabeth Clain, Julia R. Trosman, Michael P. Douglas, +2

Nature Biotechnology

Genetic TestingGene PanelsMedicineGeneticsBiostatistics +5